Amir Mohammad Emtiazjoo

Amir Emtiazjoo practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Amir Emtiazjoo's NPI, 1720310816, was assigned on February 1, 2010. Amir Emtiazjoo graduated from University Of Florida College Of Medicine in 1999. Amir Emtiazjoo holds Florida license ME119899.

Amir Emtiazjoo's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Amir Emtiazjoo's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. Amir Emtiazjoo is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Amir Emtiazjoo practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Amir Emtiazjoo's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Amir Emtiazjoo is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Amir Emtiazjoo's licenses on file in 2 states: Florida and California.

Dmand AI lists chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pulmonary fibrosis, sleep apnea and tobacco use among the conditions Amir Emtiazjoo treats.

CMS data shows 851 Medicare services from Amir Emtiazjoo across 7 procedure codes in 2024, for 161 Medicare patients. Medicare paid $79,208 for them.

CMS counts 161 Medicare patients who saw Amir Emtiazjoo in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 3.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amir Emtiazjoo's median patient age at 67, with 41% women.

In 2024, Amir Emtiazjoo wrote 159 Medicare Part D claims for 38 patients. CMS names the drug for 107 of them, across 5 drugs with 11 or more claims each, at $363,679 in total drug cost. In 2023, CMS named 137 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Amir Emtiazjoo for performance year 2024, reported through an alternative payment model (APM). CMS lists Amir Emtiazjoo as offering telehealth.

Dmand AI links 31 papers to Amir Emtiazjoo, published from 2012 to 2025. 2024 was the busiest year, with 11. The most frequent topics are Lung Transplantation, Extracorporeal Membrane Oxygenation and Respiratory Insufficiency. Amir Emtiazjoo has published most often in Ann Card Anaesth. Amir Emtiazjoo's most frequent co-authors are Tiago Noguchi Machuca, MD, Mindaugas Rackauskas, MD and Cynthia Jane Gries, MD, MS.

CMS Open Payments shows 7 general payments to Amir Emtiazjoo from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Kamada Ltd. paid the most, $182.

Amir Emtiazjoo graduated from University Of Florida College Of Medicine in 1999.

Amir Emtiazjoo is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.